PMID: 9419219Jan 31, 1998Paper

Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s

The Journal of Experimental Medicine
R BonecchiF Sinigaglia

Abstract

T helper cells type 1 (Th1s) that produce interferon-gamma predominantly mediate cellular immune responses and are involved in the development of chronic inflammatory conditions, whereas Th2s which produce large amounts of IL-4 and IL-5 upregulate IgE production and are prominent in the pathogenesis of allergic diseases. The precise factors determining whether Th1- or Th2-mediated immune responses preferentially occur at a peripheral site of antigen exposure are largely unknown. Chemokines, a superfamily of polypeptide mediators, are a key component of the leukocyte recruitment process. Here we report that among four CXC (CXCR1-4) and five CC (CCR1-5) chemokine receptors analyzed, CXCR3 and CCR5 are preferentially expressed in human Th1s. In contrast, Th2s preferentially express CCR4 and, to a lesser extent, CCR3. In agreement with the differential chemokine receptor expression, Th1s and Th2s selectively migrate in response to the corresponding chemokines. The differential expression of chemokine receptors may dictate, to a large extent, the migration and tissue homing of Th1s and Th2s. It may also determine different susceptibility of Th1s and Th2s to human immunodeficiency virus strains using different fusion coreceptors.

References

Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·C S HsiehK M Murphy
Jan 1, 1992·Annual Review of Immunology·L J Picker, E C Butcher
Jan 1, 1991·Methods in Enzymology·F SinigagliaJ R Pink
May 16, 1990·Biochemical and Biophysical Research Communications·Y Ohmori, T A Hamilton
Dec 1, 1994·European Journal of Immunology·P AllavenaA Mantovani
Jan 1, 1994·Annual Review of Immunology·S Romagnani
Jan 1, 1994·Annual Review of Immunology·P M Murphy
Jan 1, 1993·Annual Review of Immunology·M A Farrar, R D Schreiber
Jun 1, 1996·The Journal of Experimental Medicine·P D PonathC R Mackay
Jan 1, 1996·International Journal of Clinical & Laboratory Research·S SozzaniA Mantovani
Oct 31, 1996·Nature·A K AbbasA Sher
Sep 1, 1996·The Journal of Experimental Medicine·C C BleulT A Springer
Mar 3, 1997·The Journal of Experimental Medicine·L RoggeF Sinigaglia
Mar 3, 1997·The Journal of Experimental Medicine·A SicaA Mantovani
Jan 1, 1997·Annual Review of Immunology·M BaggioliniB Moser
Apr 1, 1997·Current Biology : CB·A H Lichtman, A K Abbas
Jun 15, 1997·The Journal of Clinical Investigation·D A ZismanT J Standiford
Sep 18, 1997·The Journal of Clinical Investigation·P Panina-BordignonF Sinigaglia

❮ Previous
Next ❯

Citations

Mar 23, 2000·The Journal of Pathology·W I de BoerP S Hiemstra
May 6, 1999·European Journal of Immunology·C LapentaS Fais
Jun 8, 1999·European Journal of Immunology·F SallustoA Lanzavecchia
Sep 25, 2001·The Journal of Pathology·R J Glynne, S R Watson
Mar 10, 2001·European Journal of Immunology·M VulcanoS Sozzani
Apr 12, 2001·European Journal of Immunology·A de LavareilleM Goldman
Nov 21, 2002·European Journal of Immunology·Ian P Lewkowich, Kent T HayGlass
Jan 5, 2002·Arthritis and Rheumatism·J H RuthA E Koch
Mar 29, 2002·Arthritis and Rheumatism·Masato YamadaHiroshi Hashimoto
Mar 29, 2002·International Journal of Cancer. Journal International Du Cancer·Luca PuccettiEnrico Maggi
Jun 26, 2002·The Journal of Pathology·S SchweyerA Fayyazi
Jul 13, 2000·Biochemical and Biophysical Research Communications·K J StaplesR Newton
Feb 10, 2000·Springer Seminars in Immunopathology·U SyrbeA Hamann
Feb 10, 2000·Springer Seminars in Immunopathology·L R Wedderburn, P Woo
Dec 23, 2008·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·A S Lonsdorf, A H Enk
May 12, 2005·Cancer Immunology, Immunotherapy : CII·Jose Manuel CózarFrancisco Ruiz-Cabello Osuna
Mar 31, 2010·Cancer Immunology, Immunotherapy : CII·Yuqiang Ji, Wanggang Zhang
Jan 13, 2001·Springer Seminars in Immunopathology·H YoneyamaK Matsushima
Sep 1, 2005·Rheumatology International·Huseyin T E OzerOguz Kara
Mar 28, 2007·Rheumatology International·Fulya TahanRuhan Dusunsel
Sep 16, 2004·Virchows Archiv : an International Journal of Pathology·Shigeki ShimizuRyuzo Ueda
May 25, 2006·Journal of Molecular Modeling·Kelby B NapierJohn O Trent
Jun 19, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A S MouraM O C Rocha
May 30, 2009·Cellular and Molecular Neurobiology·Majid ShahbaziMahdi Zamani
Apr 8, 2006·Journal of Clinical Immunology·Samantha W M LunChristopher W K Lam
Mar 1, 2012·Journal of Clinical Immunology·Bon-A ChoHang-Rae Kim
Mar 20, 2002·Current Allergy and Asthma Reports·T T Hansel, P J Barnes
Jun 22, 2005·Current Allergy and Asthma Reports·Andor Pivarcsi, Bernhard Homey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.